Conference KOL Highlights
ACC.26: Safety and Efficacy of New drug to Treat Uncontrolled Hypertension
HealthDay speaks with Luke Laffin, MD, Preventive Cardiologist, Cleveland Clinic about the results of the Kardinal Trial about the use of tonlamarsen in the treatment of uncontrolled hypertension.
